Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

February 2018 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In February 2018, FDA received 110,840 drug adverse event reports. In February 2017, FDA received 106,482.

In February 2018, FDA received 71,926 medical device reports. In February 2017, FDA received 75,019.

By drug reports received, February 2018 was number 9 of the 12 months of 2018. FDA received 107,389 drug reports a month on average in the 12 months before February 2018.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to February 2018
0100,000200,000201620172018

Drugs in the reports

The table has the 145 drug pages with 250 or more reports in February 2018. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of February 2018 name as a suspect product, in order of name
DrugReports in the month
Abilify2,117
Acetaminophen303
Acetylsalicylic Acid266
Actemra339
Actiq667
Advair Diskus258
Afinitor256
Alirocumab Prefilled Pen423
Alprazolam336
Ambrisentan608
Amlodipine381
Aranesp524
Aspirin432
Avastin324
Avonex473
Butrans965
Cabometyx745
Carboplatin509
Cetirizine hydrochloride294
Cisplatin306
Clarithromycin362
Clozapine341
Clozaril310
Copaxone332
Cosentyx1,456
Cyclophosphamide719
Cytarabine424
Dexamethasone1,096
Diazepam301
Dilaudid743
Docetaxel727
Doxorubicin320
Duragesic731
Dysport594
Eliquis964
Enbrel3,792
Entresto753
Etoposide373
Eylea668
Fentanyl265
Fentora669
Fluorouracil364
Forteo342
Furosemide251
Gabapentin685
Gilenya673
Harvoni265
Humalog266
Humira2,769
Hydrocodone bitartrate and acetaminophen699
Hydromorphone730
Hysingla ER685
Ibrance684
Ibuprofen388
Imbruvica566
Invega Sustenna270
Invokana352
Jakafi428
Kadian666
Keytruda317
Lamotrigine315
Levetiracetam323
Levofloxacin400
Lisinopril292
Loperamide hydrochloride306
Lyrica711
Makena2,447
Metformin425
Methotrexate1,413
Methotrexate sodium1,064
Metronidazole379
MiraLAX349
Mirena604
Mirtazapine253
Morphine sulfate337
MS Contin696
Mycophenolate mofetil306
Nerlynx478
Neulasta4,228
Nexium283
Nexplanon378
Nivolumab387
Norco685
Northera594
Novothyrox282
Nucynta696
Nuplazid987
Olanzapine290
Omeprazole400
Opana686
Opana Er685
Opdivo439
Opsumit428
Orencia653
Otezla1,498
Oxaliplatin358
Oxycodone hydrochloride1,839
OxyContin742
Oxymorphone hydrochloride584
Paclitaxel331
Pantoprazole346
Paracetamol349
ParaGard T 380A290
Percocet711
Percodan667
Pomalyst485
Pradaxa425
Praluent473
Prednisolone549
Prednisone890
Prolia720
Quetiapine333
Regranex254
Remicade704
Repatha333
Restasis1,284
Revlimid1,920
Risperdal341
Risperidone289
Rituximab477
Sertraline281
Simponi377
Soliris358
Stelara566
Subsys601
Sulfasalazine256
Tacrolimus550
Taxotere333
Tecfidera845
Tiotropium bromide270
Tramadol304
Trulicity497
TYLENOL Extra Strength261
Tymlos298
Tysabri687
Ventolin Hfa337
Vincristine511
Warfarin290
Womens Rogaine Unscented256
Xarelto1,250
Xeljanz1,054
Xolair1,941
Xyrem351
Zydone646
Zytiga401

Reaction terms in the reports

The table has the 115 reaction terms with 500 or more reports in February 2018. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of February 2018 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort972
Abdominal distensiona bloated abdomen532
Abdominal painstomach or belly pain1,193
Abdominal pain upperupper stomach pain995
Accidental exposure to product724
Acute kidney injurysudden loss of kidney function1,141
Adverse eventan unwanted medical event, type not specified614
Alopeciahair loss1,515
Anaemialow red blood cells993
Anxietyanxiety1,367
Arthralgiajoint pain1,718
Astheniaweakness or lack of energy1,899
Atrial fibrillationan irregular heart rhythm552
Back painback pain1,128
Blood glucose increasedraised blood sugar reading725
Blood pressure increaseda raised blood pressure reading749
Bronchitischest infection553
Cerebrovascular accidentstroke713
Chest painchest pain893
Chillschills or shivering551
Completed suicidedeath by suicide895
Condition aggravatedthe condition being treated got worse1,298
Confusional stateconfusion967
Constipationconstipation1,141
Coughcough1,515
Deaththe patient died; cause not stated by this term4,957
Decreased appetitereduced appetite1,298
Dehydrationdehydration658
Depressionlow mood1,067
Diarrhoealoose or frequent stools3,595
Disease progressionthe disease advanced508
Dizzinesslight-headedness or unsteadiness2,559
Drug abusemisuse of a medicine506
Drug dose omissiona dose was missed2,548
Drug effect decreasedthe medicine had less effect562
Drug effect incomplete671
Drug hypersensitivityan allergic-type reaction (the term names a medicine)1,847
Drug ineffectivethe medicine did not work as expected7,297
Drug interactionan interaction between medicines883
Drug intolerancethe medicine was not tolerated576
Dyspnoeashortness of breath3,092
Epistaxisnosebleed508
Erythemaskin redness803
Eye irritationeye irritation638
Falla fall1,887
Fatiguetiredness4,054
Feeling abnormalfeeling odd or not right1,324
Foetal exposure during pregnancythe unborn baby was exposed to the medicine522
Gait disturbancedifficulty walking1,022
Gastrointestinal haemorrhagebleeding in the stomach or bowel540
Hallucinationseeing or hearing things that are not there642
Headachehead pain3,327
Hospitalisationadmission to hospital987
Hyperhidrosisexcessive sweating758
Hypersensitivityan allergic-type reaction904
Hypertensionhigh blood pressure1,002
Hypoaesthesianumbness765
Hypotensionlow blood pressure960
Inappropriate schedule of drug administrationthe medicine was taken at the wrong times1,567
Incorrect dose administeredthe wrong dose was given1,057
Infectionan infection, type not specified679
Influenzaflu1,805
Injection site painpain where the injection was given925
Insomniadifficulty sleeping1,298
Intentional product misusedeliberate use not as intended773
Intentional product use issuedeliberate use not as intended615
Loss of consciousnesspassing out735
Malaisegeneral feeling of being unwell2,853
Malignant neoplasm progression766
Memory impairmentmemory problems773
Muscle spasmsmuscle cramps999
Muscular weaknessmuscle weakness581
Myalgiamuscle pain910
Myocardial infarctionheart attack600
Nasopharyngitisa cold1,216
Nauseafeeling sick4,075
Neutropenialow neutrophils, a type of white blood cell734
No adverse eventno adverse event was reported1,057
Off label useused for a purpose or in a way not on the label4,687
Overdosea dose above the recommended amount792
Painpain, site not specified2,587
Pain in extremitypain in an arm or leg1,475
Palpitationsawareness of the heartbeat641
Paraesthesiatingling or pins and needles740
Peripheral swellingswelling of the arms or legs978
Pneumonialung infection2,046
Premature babya baby born early789
Premature delivery753
Product quality issuea problem with the product itself858
Product storage errorthe product was stored wrongly541
Product use in unapproved indicationused for a purpose not on the label1,893
Product use issuea problem in how the product was used966
Pruritusitching1,583
Psoriasispsoriasis, a skin condition701
Pyrexiafever1,683
Rashskin rash1,839
Renal failurekidney failure622
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease542
Seizurea fit or convulsion786
Sepsisa severe body-wide response to infection629
Sinusitissinus infection545
Somnolencedrowsiness1,026
Thrombocytopenialow platelets636
Toxicity to various agentspoisoning or toxic effect of one or more substances3,207
Tremorshaking809
Underdoseless than the intended dose754
Urinary tract infectionbladder or urinary infection891
Urticariahives928
Vision blurredblurred vision819
Visual impairmentreduced vision707
Vomitingbeing sick2,346
Weight decreasedweight loss1,386
Weight increasedweight gain1,048
White blood cell count decreasedlow white cell count587
Wrong technique in product usage processthe product was used in the wrong way3,131

Devices in the reports

The table has the 75 device pages with 100 or more reports in February 2018. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of February 2018 name, in order of name
Brand nameReports in the month
530g Insulin Pump Mmt-751nas177
630G Insulin PUMP MMT-1715K 630G BLACK MG664
640G Insulin Pump MMT-1711K484
640g Insulin Pump Mmt-1712b105
640G Insulin Pump MMT-1712K475
Accu-Chek Spirit Combo139
Activa228
Animas Insulin Cartridge180
Animas Vibe1,809
Arctic Sun 5000102
Attain Performa131
Bravo118
Capsurefix Novus1,224
Carelink122
Confirm128
Dexcom G4 Platinum Continuous Glucose Monitoring System662
Dexcom G5 Mobile Continuous Glucose Monitoring System8,895
Durata Sts Optim Active Fixation Df-4 Connector143
Endo GIA437
Endo GIA Ultra229
Eon Mini IPG, 16-Channel Rechargeable101
Essure503
FreeStyle Freedom Lite197
FreeStyle Libre111
FreeStyle Lite181
FreeStyle Precision Neo237
Heart Start XL121
Heartstart Mrx131
HeartStart MRx -EMS Defibrillator136
Heartstart Onsite120
HeartStart XL+ Defibrillator/Monitor131
Implantable Collamer Lens Icl123
Intellis133
Intellivue Information Center Ix182
Intralase151
Kangaroo206
LifeVest WCD 4000 System790
MENTOR Smooth Round Moderate Profile156
Mitraclip System Clip Delivery System Nt101
MMT-712 PARADIGM Insulin Pump136
Ni376
Octrode Lead Kit, 60cm Length268
OmniPod Insulin Pump675
Paradigm Real-Time Revel Insulin Infusion Pump Mmt-723nas117
Perclose Proglide 6f Suture Mediated Closure Smc System296
Piic Ix Hardware100
Precision Spectra ?154
Precision Xtra156
Proclaim 5 Elite198
Proclaim 7 Elite127
Pump Mmt-1715km 630g 3ml Black Medi114
Pump Mmt-1780k 670g 3ml Black146
Pump MMT-1780KPK 670G Pathway Black MG928
Quadra Assura MP ICD105
Quartet101
Reservoir 3ML MMT-332A136
Reveal LINQ343
Selectsecure108
Sensor Enlite Mmt-7008a210
Spectrum Infusion Pump402
Sprint Quattro Secure331
Sprint Quattro Secure S370
Style 68 Saline Filled Breast Implant377
SureScan486
Synergy124
Synvisc One129
T Flex Insulin Delivery System166
T Slim G5 System1,162
t:slim G4 system568
t:slim Insulin Delivery System565
t:slim X2 Insulin Pump506
Tandem T Slim Insulin Delivery System335
Tendril Sts184
Trilogy 100212
V60 Ventilator164

Cite this page

Reported Reactions. February 2018: adverse event reports received by FDA. https://reportedreactions.com/month/2018-02/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for February 2018 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 110,840 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.